Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liuling Jiedu Pill
- Development stage
- Unknown
- Lead developer
- Changshu Leiyunshang Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Liuling Jiedu Pill (六灵解毒丸) is a traditional Chinese medicine (TCM) formulated as black micro-pills. It is developed and manufactured by Changshu Leiyunshang Pharmaceutical (a subsidiary of Lei Yun Shang Pharmaceutical Group). The formulation is derived from the classic warm disease theories of the Wu School of Chinese Medicine (吴门医派温病学). Its primary active ingredients include artificial calculus bovis (artificial cow bezoar), pearl, and Acorus tatarinowii, among other herbs. Liuling Jiedu Pill is clinically indicated for clearing heat, detoxifying, reducing swelling, and relieving pain. It is commonly used to treat acute pharyngitis, sore throat, tonsillitis (single or double tonsillar abscesses), scarlet fever, and various skin infections such as boils, carbuncles, and furuncles.
- Brand names
- Lei Yun Shang雷允上
- Other names
- LIU LING JIE DU WANLiuling Jiedu Wan六灵解毒丸
02
Targets
IFNG (Interferon gamma)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Liuling Jiedu Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liuling Jiedu Pill.